Sionna Therapeutics (SION) shares fell nearly 14% in recent Monday trading after RBC Capital Markets downgraded the stock to underperform from sector perform, while keeping its $24 price target.
Trading volume stood at over 526,000, versus the daily average of about 300,000.
Price: 37.53, Change: -6.04, Percent Change: -13.86